Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2007

01.04.2007 | Original Paper

Off-label prescribing in a French hospital

verfasst von: Audrey Cras, Marie-Agnès Conscience, Gérald Rajzbaum, Agnès Lillo-Le Louët, Nathalie Lopez, Isabelle Tersen, Yvonnick Bezie

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

In contrast to paediatrics patients, data concerning the extent of off-label prescribing for adult patients are limited. The aim of our study was to investigate the frequency of off-label drug use for adult patients in a French general hospital.

Method

The study was conducted on a Wednesday in November 2004. Prescribing was prospectively assessed on the basis of conformity with the marketing authorizations.

Results

A total of 1341 prescriptions for 192 hospitalized patients were analysed. Twenty three per cent of the prescriptions were off-label. Among all patients, 70% received at least one off-label medicine. Most off-label prescriptions were related to an unapproved indication (75%). The main other reasons were dosage (14%) and dosing schedule (9%). Anti-thrombotic and anti-ulcer agents were found on more than 40% of the off-label prescriptions.

Conclusion

Off-label prescriptions occur frequently in the hospital and often alternatives with the proper marketing authorizations are available. An increased involvement of hospital pharmacists should reduce the incidence of off-label prescribing and thus contribute to patient safety and possibly cost reduction.
Literatur
1.
Zurück zum Zitat Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 2003;17:125–1. Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 2003;17:125–1.
2.
Zurück zum Zitat Poole S, Dooley M. Off-label prescribing in oncology. Support Care Cancer 2004;12:302–5. Poole S, Dooley M. Off-label prescribing in oncology. Support Care Cancer 2004;12:302–5.
3.
Zurück zum Zitat Albaladejo P, Caillet B, Moine P, et al. Off-label prescriptions in an adult surgical intensive care unit. Presse Med 2001;30:1484–8. Albaladejo P, Caillet B, Moine P, et al. Off-label prescriptions in an adult surgical intensive care unit. Presse Med 2001;30:1484–8.
4.
Zurück zum Zitat Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004;13:147–52. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004;13:147–52.
5.
Zurück zum Zitat Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 2004;3:81–3. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 2004;3:81–3.
6.
Zurück zum Zitat Kucukarslan S, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014–8. Kucukarslan S, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014–8.
7.
Zurück zum Zitat Radley CD, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021–26. Radley CD, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021–26.
8.
Zurück zum Zitat Samama M, Cohen A, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793–800. Samama M, Cohen A, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793–800.
9.
Zurück zum Zitat Eidelman R, Hebert P, Weisman S, et al. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006–10. Eidelman R, Hebert P, Weisman S, et al. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006–10.
10.
Zurück zum Zitat Kivioja A, Linnosmaa I, Vehvilainen A, et al. Costminimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. Eur J Pharm Sci 2004;21:171–8. Kivioja A, Linnosmaa I, Vehvilainen A, et al. Costminimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. Eur J Pharm Sci 2004;21:171–8.
11.
Zurück zum Zitat Bates D, Leape L, Cullen D, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311–3. Bates D, Leape L, Cullen D, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311–3.
Metadaten
Titel
Off-label prescribing in a French hospital
verfasst von
Audrey Cras
Marie-Agnès Conscience
Gérald Rajzbaum
Agnès Lillo-Le Louët
Nathalie Lopez
Isabelle Tersen
Yvonnick Bezie
Publikationsdatum
01.04.2007
Verlag
Kluwer Academic Publishers
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2007
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-006-9064-0

Weitere Artikel der Ausgabe 2/2007

International Journal of Clinical Pharmacy 2/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.